The Pfizer-BioNTech Covid-19 vaccine will begin a new trial to test its effectiveness in children beginning this month in Rochester.
Researchers are enrolling participants in pediatric trials beginning June 7 at the University of Rochester Medical Center.
Children between the ages of 5 and 11 will be enrolled in Phase 2 and 3 trials, involving mid-to-large population groups in different communities.
URMC will be participating in future trials for both the Pfizer and Moderna vaccines for children between the ages of 6 months and 4 years.
Parents interested in enrolling their child in the trials can learn more here.
Earlier in the year, Rochester Clinical Research used 45 local children between the ages of 12 and 15 for a vaccine trial. The 11 and under age group is recruiting over 100 patients.
FingerLakes1.com is the region’s leading all-digital news publication. The company was founded in 1998 and has been keeping residents informed for more than two decades. Have a lead? Send it to [email protected]